ACIM
GSK icon

Azimuth Capital Investment Management’s GSK GSK Stock Holding History

Azimuth Capital Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,060
Closed -$274K – 300
2025
Q1 		$274K Hold
7,060
– – 0.01% 277
2024
Q4 		$239K Buy
7,060
+200
+3% +$7.2K 0.01% 289
2024
Q3 		$280K Hold
6,860
– – 0.01% 280
2024
Q2 		$264K Hold
6,860
– – 0.01% 285
2024
Q1 		$294K Buy
6,860
+900
+15% +$37.1K 0.01% 270
2023
Q4 		$221K Buy
+5,960
New +$214K 0.01% 290

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Azimuth Capital Investment Management's GSK Position: Q2 2025 in Review

Azimuth Capital Investment Management sold out of GSK (GSK) in Q2 2025, closing a stake of 7,060 shares — an estimated $274K sold.

Azimuth Capital Investment Management first reported a position in GSK in Q4 2023 and held it in 6 quarters. The position peaked at $294K in Q1 2024. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • Azimuth Capital Investment Management reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
  • Azimuth Capital Investment Management sold 7,060 GSK shares in Q2 2025, an estimated $274K.
  • Azimuth Capital Investment Management first reported a position in GSK in Q4 2023 and held it in 6 quarters.
  • Azimuth Capital Investment Management's GSK position peaked at $294K in Q1 2024.
  • 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Azimuth Capital Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.